Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_3
4
67%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (16.7%)
Phase 34 (66.7%)
N/A1 (16.7%)

Trials by Status

terminated117%
completed583%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis

NCT00151892
terminatednot_applicable

Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients

NCT00349388
completedphase_1

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

NCT00751699
completedphase_3

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

NCT01257386
completedphase_3

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

NCT01257399
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT00151892Phase 3

Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis

Completed
NCT00349388Not Applicable

Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients

Terminated
NCT00751699Phase 1

Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers

Completed
NCT01257386Phase 3

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

Completed
NCT01257399Phase 3

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

Completed
NCT00092508Phase 3

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6